StockNews.AI
ONC
StockNews.AI
124 days

BeiGene to Announce First Quarter 2025 Financial Results on May 7

1. ONC to change name to BeOne Medicines, Q1 2025 results on May 7.

2m saved
Insight
Article

FAQ

Why Neutral?

The name change may indicate a strategic shift, but financial results are pending.

How important is it?

Financial performance will clarify the company's direction but is not immediately impactful.

Why Short Term?

Market reactions may manifest around the Q1 2025 financial results and webcast event.

Related Companies

BGBABBVMRNA
SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeiGene--BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., will report its first quarter 2025 financial results on Wednesday, May 7, 2025 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. The conference call will be webcast live and a link to the webcast can be accessed from the investo.

Related News